Search for: "Boehringer Ingelheim, Inc."
Results 41 - 60
of 155
Sorted by Relevance
|
Sort by Date
15 Jan 2014, 5:43 am
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
17 Dec 2010, 11:05 am
Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. [read post]
14 Mar 2012, 10:42 am
Boehringer Ingelheim Pharmaceuticals Inc., et al.; U.S. [read post]
20 Aug 2012, 11:15 am
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against… [read post]
19 Dec 2010, 9:44 am
--Naik v Boehringer Ingelheim Pharm, Inc., 7thCir, November 22, 2010, No. 09-2960: Summary judgment upheld for employer after 53-year-old former pharmaceutical sales rep failed to show that termination based on falsification of call records, was pretext for age and national origin (Indian) discrimination in violation of the Age Discrimination in Employment Act (ADEA) and Title VII.The employer's legitimate non-discriminatory reason (LNDR) was pretty damning against… [read post]
21 Mar 2017, 12:23 pm
Boehringer Ingelheim Pharmaceuticals, Inc. markets this prescription anticoagulant drug. [read post]
7 May 2010, 1:07 pm
Boehringer Ingelheim International GMBH v. [read post]
11 Nov 2019, 3:21 am
In re Boehringer Ingelheim Vetmedica, Inc., Serial No. 87072333 (November 6, 2019) [not precedential] (Opinion by Judge David Mermelstein).During examination, the USPTO must analyze the specimens of use to determine whether the purported mark would be perceived as a source indicator. [read post]
28 Jul 2011, 11:19 am
Boehringer Ingelheim Pharmaceuticals, No. 10-3129, slip op. (8th Cir. [read post]
13 Nov 2019, 9:15 am
In Celltrion, Inc. v. [read post]
11 Jan 2018, 12:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
25 Jan 2014, 9:43 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
12 Apr 2023, 4:00 am
Sandoz Canada Inc., 2023 FC 243 at para 29. [6] See Boehringer Ingelheim (Canada) Ltd. v. [read post]
13 Jul 2016, 1:56 pm
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
28 Jan 2014, 11:53 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
29 Aug 2007, 10:22 am
Boehringer Ingelheim Vetmedica, Inc. (17-CA-22964; 350 NLRB No. 60) St. [read post]
14 Oct 2009, 12:31 pm
The consent order requires Pfizer to sell approximately half of Wyeth’s Fort Dodge U.S. animal health business, including vaccines for cattle, dogs, and cats, and other pharmaceutical products used in treating cattle, dogs, cats, and horses, to Boehringer Ingelheim Vetmedica, Inc. [read post]
TTAB Test: Is "BREATHLESS" Merely Descriptive of Idiopathic Pulmonary Fibrosis Information Services?
29 Nov 2017, 3:29 am
In re Boehringer Ingelheim Pharmaceuticals, Inc., Serial No. 86852106 (November 27, 2017) [not precedential] (Opinion by Judge Frances Wolfson).The Board ignored applicant's feeble double entendre argument, but it agreed with applicant that the USPTO's evidence failed to show that the term "breathless" merely describes the subject services. [read post]
23 Jan 2013, 4:16 pm
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
24 Dec 2013, 5:49 am
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
